← All Q32 Bio INC filings

Q32 Bio INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
QTTB
Q32 Bio INC
SCHEDULE: OrbiMed Files Amendment to Schedule 13D for Q32 Bio Inc.
OrbiMed Advisors LLC and affiliated entities have filed an amendment to their Schedule 13D, reporting a decrease in their beneficial ownership of Q32 Bio Inc. common stock due to an increase in outstanding shares.
NASDAQ
QTTB
Q32 Bio INC
SCHEDULE: OrbiMed Increases Stake in Q32 Bio via Private Placement
OrbiMed Advisors and affiliates have increased their beneficial ownership in Q32 Bio Inc. to 17.4% following a recent private placement.
NASDAQ
QTTB
Q32 Bio INC
SCHEDULE: Atlas Venture Increases Stake in Q32 Bio via PIPE
Atlas Venture entities acquired 625,000 shares of Q32 Bio Inc. in a private placement, bringing their total beneficial ownership to 11.5%.
NASDAQ
QTTB
Q32 Bio INC
SCHEDULE: OrbiMed Advisors Updates Q32 Bio Beneficial Ownership
OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC filed an amendment to their Schedule 13D reporting a change in beneficial ownership percentage in Q32 Bio Inc.
NASDAQ
QTTB
Q32 Bio INC
SCHEDULE: OrbiMed Amends Q32 Bio Stake, Ownership Dips to 15.4%
OrbiMed Advisors and OrbiMed Capital GP VII LLC filed an amended Schedule 13D, reporting a decrease in their beneficial ownership of Q32 Bio Inc. common stock to 15.4% due to an increase in the issuer's outstanding shares.